Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
Patients suffering from several dermatologic diseases and conditions including acne, rosacea, and pruritus can largely benefit from the new and exciting therapies and treatment modalities that have recently become available.
Click here to answer this week's poll.
AAD vice president challenges dermatologists to advocate for their patients and themselves.
A survey conducted by Dermatology Times® found that many still cannot access the iPLEDGE system. Now some have created guides to get around the issue.
In this week’s Pointers with Dr Portela, the 208SkinDoc had already called out the Green Mask Stick’s false advertising, but now the controversy continues.
With the complication rate of treatment declining and new devices now available, laser- and energy-based light treatment for acne and scarring continues to evolve.
In this week’s Pointers with Dr Portela, the 208SkinDoc lists his favorite skincare products that he used this year.
The recent approval of a topical androgen receptor inhibitor fills a longtime need in acne treatment.
Click here to answer this week's poll.
John Barbieri, MD, MBA, FAAD, speaking in his capacity as a member of the AADA iPLEDGE Workgroup, talks with Dermatology Times® about the recent iPLEDGE website struggles and guidance on how dermatologists should handle the situation.
Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.
A study investigated the acceptability and validity of patient-reported outcome measures for adult acne, comparing them to the validated acne-specific quality-of-life measure.
Click here to answer this week's poll.
This letter to the editor in the Journal of the American Academy of Dermatology investigated how mental health and its association to race and ethnicity relate to patients with acne.
Here is what to expect from the “Getting to the Roots of Childhood Acne” live virtual webinar happening December 15 at 6:30 p.m.
In this week’s Pointers with Dr Portela, the 208SkinDoc answers viewer questions about acne scarring including how to distinguish between acne scars and inflammatory pigment change.
Twenty four international plastic surgeons and dermatologists came together to provide a consensus on the treatment of acne scars.
In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the Clear Start Acne kit and takes a deep dive on the ingredients in the products.
A study in the Journal of the American Academy of Dermatology investigated Instagram’s content on acne and its quality.
This study aimed to examined morbidity associated with truncal acne.
In this exclusive interview with Dermatology Times, David Goldberg, MD, JD, explains why lasers are a treatment option in acne and the latest advancements in the field.
In this exclusive video interview with Dermatology Times, Michael Gold, MD, tells us about his session at the New Frontiers in Cosmetic Medicine and Medical Dermatology Symposium.
Sun Pharma has announced that their Winlevi 1% cream is now available in the US to treat acne vulgaris in patients 12 years and older.
